Epysqli

उत्पाद अवलोकन

About Epysqli

Epysqli is a medication containing the active ingredient eculizumab, classified as Complement Inhibitor. Eculizumab, sold under the brand name Soliris among others, is a recombinant humanized monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE BKEMV is a complement inhibitor indicated for: The treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to.
• Used for: 1 ) The treatment of patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

eculizumab, the active ingredient in Epysqli, belongs to the Complement Inhibitor class. 1 INDICATIONS AND USAGE BKEMV is a complement inhibitor indicated for: The treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis. ( 1. 1 ) The treatment of patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Epysqli. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Epysqli for extended periods without medical advice.